SM
Sofinnova Management VIII, L.L.C.
Momentum followerQuality / disciplined sizingConcentrated strategy
Total reported value
$183.2M
Reporting period: 2017-12-31 · Number of holdings: 8
Sofinnova Management VIII, L.L.C. disclosed 8 holdings in its latest 13F filing for the period ending 2017-12-31, with total reported value of $183.2M and a quarterly turnover rate of 47.6%.
Personality snowflake
- Concentration
- 79.62
- Portfolio Stability
- 47.61
- Momentum/Contrarian
- 100
- Sector conviction
- 0
- Diversification
- 16
- Sizing Uniformity
- 91.77
Recent moves
Add 67022C106
+600.0% $34.9M
Trim ONCEEUR
0.0% -$18.2M
Add H5861P103
+26.7% $15.8M
Trim NTRA
0.0% -$6.0M
Trim ACRS
0.0% -$1.8M
Trim 87166L100
0.0% -$4.0M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Nucana PLC Sponsored Adr | Stock-Other | 25.76% | +18.29% | +600.00% | |
| 2 | ✓ | Obseva SA | Stock-Other | 25.31% | +6.70% | +26.67% | |
| 3 | ACRS | Aclaris Therapeutics INC | Stock-Other | 20.72% | -3.51% | — | |
| 4 | ONCEEUR | Spark Therapeutics INC | Stock-Other | 13.51% | -12.65% | — | |
| 5 | NTRA | Natera INC | Stock-Healthcare | 7.61% | -4.57% | — | |
| 6 | ✓ | Auris Med Hldg AG | Stock-Other | 2.52% | -1.39% | — | |
| 7 | ✓ | Histogenics CORP | Stock-Other | 2.32% | -0.19% | — | |
| 8 | ✓ | Synlogic INC | Stock-Other | 2.25% | -2.68% | — |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
Holding changes this quarter
Sofinnova Management VIII, L.L.C.'s most significant position changes for 2017-12-31: Add: Nucana PLC Sponsored Adr — shares +600.00%; Add: Obseva SA — shares +26.67%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Nucana PLC Sponsored Adr | +18.3% | +600.00% | Add |
| 2 | ✓ | Obseva SA | +6.7% | +26.67% | Add |
| 3 | ✓ | Histogenics CORP | -0.2% | — | Unchanged |
| 4 | ✓ | Auris Med Hldg AG | -1.4% | — | Unchanged |
| 5 | ✓ | Synlogic INC | -2.7% | — | Unchanged |
| 6 | ACRS | Aclaris Therapeutics INC | -3.5% | — | Unchanged |
| 7 | NTRA | Natera INC | -4.6% | — | Unchanged |
| 8 | ONCEEUR | Spark Therapeutics INC | -12.7% | — | Unchanged |
FAQ
What is Sofinnova Management VIII, L.L.C. and what type of investor is it?
Sofinnova Management VIII, L.L.C. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2017-12-31), the firm manages a tracked equity portfolio valued at approximately $183.2M, spread across 8 disclosed positions.
What are Sofinnova Management VIII, L.L.C.'s largest equity positions?
Based on the latest 13F filing, Sofinnova Management VIII, L.L.C.'s top holdings by market value are:
1. Nucana PLC Sponsored Adr — $47.2M (25.8%)
2. Obseva SA — $46.4M (25.3%)
3. Aclaris Therapeutics INC (ACRS) — $38.0M (20.7%)
4. Spark Therapeutics INC (ONCEEUR) — $24.7M (13.5%)
5. Natera INC (NTRA) — $13.9M (7.6%)
What changes did Sofinnova Management VIII, L.L.C. make in its most recent portfolio filing?
In the latest quarter, Sofinnova Management VIII, L.L.C. was primarily adding exposure — initiating 0 new positions and adding to 2 existing holdings. The largest of these moves: Add: Nucana PLC Sponsored Adr — shares +600.00%; Add: Obseva SA — shares +26.67%
What sectors does Sofinnova Management VIII, L.L.C. focus on?
Sofinnova Management VIII, L.L.C. is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%